Koninklijke Philips N.V. (PHG)
PHG vs. RMD: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical - Products sector might want to consider either Royal Philips (PHG) or ResMed (RMD). But which of these two stocks offers value investors a better bang for their buck right now?
Royal Philips (PHG) CEO on Earnings, Healthcare Brands
Roy Jakobs, CEO of Royal Philips, joins Oliver Renick to sift through the company's latest quarterly figures. Shares of PHG (@Philips) tumbled in premarket trading as the company cut its guidance due to "significant deterioration" in China demand.
Koninklijke Philips N.V. (PHG) Q3 2024 Earnings Call Transcript
Koninklijke Philips N.V. (NYSE:PHG ) Q3 2024 Results Conference Call October 28, 2024 5:00 AM ET Company Participants Leandro Mazzoni - Head of Investor Relations Roy Jakobs - Chief Executive Officer Charlotte Hanneman - CFO Conference Call Participants Richard Felton - Goldman Sachs Hassan Al-Wakeel - Barclays David Adlington - JPMorgan Lisa Clive - Bernstein Graham Doyle - UBS Hugo Solvet - Exane BNP Paribas Julien Dormois - Jefferies Robert Davies - Morgan Stanley Falko Friedrichs - Deutsche Bank Ed Ridley-Day - Redburn Leandro Mazzoni Hi, everyone.
Philips Stock Tanks on Outlook Cut as Demand Deteriorates in China
American depositary receipts (ADRs) of Koninklijke Philips (PHG) are tumbling more than 15% in premarket trading Monday after the Dutch conglomerate cut its 2024 sales outlook amid a "significant deterioration" in Chinese demand.
Dutch Health Tech Firm Philips' Q3 Earnings Miss Expectations, Lowers Annual Forecasts On Weak Demand In China
On Monday, Koninklijke Philips NV PHG reported third-quarter adjusted EPS of 0.32 euros (or $0.35), missing the consensus of 0.35 euros.
China's Weak Economy Is Weighing on Stocks. Philips Is the Latest to Suffer.
It's a reminder of how sluggish demand in the world's second-largest economy could cause problems for the likes of Starbucks and Marriott.
Philips shares slide as company blames China for lowered sales outlook
Shares of Philips slumped on Monday as the Dutch healthcare devices company lowered its sales outlook for the year.
'We need to adjust to a new speed of growth in China,' Philips CEO says
Roy Jakobs, CEO of Philips, discusses the health care device maker's third-quarter results.
Are Investors Undervaluing Koninklijke Philips (PHG) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Royal Philips (PHG) is a Strong Momentum Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
PHG or RMD: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both Royal Philips (PHG) and ResMed (RMD). But which of these two stocks offers value investors a better bang for their buck right now?
Philips: Moving Out Of Intensive Care
Philips has transformed into a healthcare technology company but faces challenges from a massive respirator recall impacting reputation, sales, and stock valuation. Despite past struggles, Philips is integrating AI into products to enhance diagnostics and productivity, aiming for 5% revenue growth and 18% margins by 2026. The stock is discounted at 10x P/cash earnings, offering potential upside with a 2025 price target of $36 and a 2026 target of $39.
